These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 3895659)

  • 1. Cyclosporine-induced chronic nephropathy in human recipients of cardiac allografts.
    Moran M; Tomlanovich S; Myers BD
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):185-90. PubMed ID: 3895659
    [No Abstract]   [Full Text] [Related]  

  • 2. Cyclosporine-associated chronic nephropathy.
    Myers BD; Ross J; Newton L; Luetscher J; Perlroth M
    N Engl J Med; 1984 Sep; 311(11):699-705. PubMed ID: 6382005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is cyclosporine A-induced nephrotoxicity in recipients of renal allografts progressive?
    Thiel G; Mihatsch M; Landmann J; Hermle M; Brunner FP; Harder F
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):169-78. PubMed ID: 3895657
    [No Abstract]   [Full Text] [Related]  

  • 4. Triple therapy with low-dose cyclosporine, azathioprine, and steroids: long-term results of a randomized study in cadaver donor renal transplantation.
    Fries D; Hiesse C; Santelli G; Gardin JP; Cantarovich M; Lantz O; Charpentier B; Paillard M; Benoit G
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):130-5. PubMed ID: 3291226
    [No Abstract]   [Full Text] [Related]  

  • 5. The case against conversion to azathioprine in cyclosporine-treated renal recipients.
    Flechner SM; Lorber M; Van Buren C; Kerman R; Kahan BD
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):276-81. PubMed ID: 3895667
    [No Abstract]   [Full Text] [Related]  

  • 6. Is chronic nephrotoxicity of cyclosporine avoided by the triple drug regimen?
    Hiesse C; Gardin JP; Lantz O; Cantarovich M; Bensadoun H; Benoit G; Bellamy J; Paillard M; Charpentier B; Fries D
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1534-6. PubMed ID: 2652495
    [No Abstract]   [Full Text] [Related]  

  • 7. Results of "immunoconversion" from cyclosporine to azathioprine in heart transplant recipients with progressive nephrotoxicity.
    Hunt SA; Stinson EB; Oyer PE; Billingham ME; Gamberg P; Miller J; Schroeder JS; Baldwin JC; Shumway NE
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2522-4. PubMed ID: 3274554
    [No Abstract]   [Full Text] [Related]  

  • 8. Evolution of renal dysfunction and hypertension in heart transplant recipients.
    Loertscher R; Fitchett DH; Marpole DG; Guerraty AJ
    Transplant Proc; 1988 Dec; 20(6):1225-7. PubMed ID: 3059607
    [No Abstract]   [Full Text] [Related]  

  • 9. Cyclosporine nephrotoxicity in orthotopic liver transplantation.
    Gonwa TA; Poplawski SC; Husberg BS; Nery JR; Klintmalm GB
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):401-4. PubMed ID: 3291276
    [No Abstract]   [Full Text] [Related]  

  • 10. Limitations of creatinine in quantifying the severity of cyclosporine-induced chronic nephropathy.
    Tomlanovich S; Golbetz H; Perlroth M; Stinson E; Myers BD
    Am J Kidney Dis; 1986 Nov; 8(5):332-7. PubMed ID: 3538857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Morphological patterns in cyclosporine-treated renal transplant recipients.
    Mihatsch MJ; Thiel G; Basler V; Ryffel B; Landmann J; von Overbeck J; Zollinger HU
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):101-16. PubMed ID: 3895652
    [No Abstract]   [Full Text] [Related]  

  • 12. Functional consequences and risk factors of chronic cyclosporine nephrotoxicity in type I diabetes trials.
    Feutren G
    Transplant Proc; 1988 Jun; 20(3 Suppl 4):356-66. PubMed ID: 3381298
    [No Abstract]   [Full Text] [Related]  

  • 13. Prospective serial renal function studies in patients with nonrenal disease treated with cyclosporine A.
    Tegzess AM; Doorenbos BM; Minderhoud JM; Donker AJ
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):390-3. PubMed ID: 3363645
    [No Abstract]   [Full Text] [Related]  

  • 14. Long-term renal function in heart transplant recipients receiving cyclosporine therapy.
    Goral S; Ynares C; Shyr Y; Yeoh TK; Johnson HK
    J Heart Lung Transplant; 1997 Nov; 16(11):1106-12. PubMed ID: 9402509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of cyclosporine A on long-term renal function in pediatric liver transplant recipients.
    Andrews WA; Arant BS; Fyock B; Gray S; Schlatter MG; Conlin C
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1452-3. PubMed ID: 1989261
    [No Abstract]   [Full Text] [Related]  

  • 16. Nephrotoxicity of cyclosporine in autoimmune diseases.
    Hannedouche TP; Delgado AG; Gnionsahe AD; Boitard C; Noël LH; Grünfeld JP
    Adv Nephrol Necker Hosp; 1990; 19():169-85. PubMed ID: 2105578
    [No Abstract]   [Full Text] [Related]  

  • 17. Cyclosporine nephrotoxicity and the consequences of conversion to azathioprine.
    Chapman JR; Morris PJ
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):254-60. PubMed ID: 3895664
    [No Abstract]   [Full Text] [Related]  

  • 18. Cyclosporine, azathioprine, and prednisone as treatment for cyclosporine-induced nephrotoxicity in renal transplant recipients.
    Lorber MI; Flechner SM; Van Buren CT; Kerman RH; Kahan BD
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):282-5. PubMed ID: 3895668
    [No Abstract]   [Full Text] [Related]  

  • 19. Intravenous cyclosporine to induce immunosuppression in cardiac allograft recipients.
    Macris MP; Frazier OH; Van Buren CT; Duncan JM
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):311-5. PubMed ID: 3291261
    [No Abstract]   [Full Text] [Related]  

  • 20. Renal function and blood pressure in heart transplant recipients treated with cyclosporine.
    Rottembourg J; Mattei MF; Cabrol A; Leger P; Aupetit B; Beaufils H; Gluckman JC; Pavie A; Gandjbakhch I; Cabrol C
    J Heart Transplant; 1985; 4(4):404-8. PubMed ID: 3916515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.